APRIL (a proliferation-inducing ligand) and BLyS (B lymphocyte stimulator) expression have been reported in chronic lymphocytic leukemia (CLL) cells. We examined APRIL and BLyS serum levels in CLL patients and evaluated the prognostic significance of APRIL expression on survival.
APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival
Planelles, L.; Castillo-Gutierrez, S.; Medema, J. P.; Morales-Luque, A.; Merle-Beral, H.; Hahne, M.
Haematologica-the Hematology Journal
2007-09 / vol 92 / pages 1284-1285
IGMM team(s) involved in this publication
Inflammation and Cancer
baff; april serum levels; llc; overall survival; prognostic factor